Behcet's syndrome: prevalence of clinical characteristics in three countries (Turkey, United States and the Netherlands)

Behcet's syndrome: prevalence of clinical characteristics in three countries (Turkey, United States and the Netherlands) - Behcet study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33363

Enrollment

Registered

2009-03-23

Start date

2009-09-10

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behcet Syndrome

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult patients who fullfill the international criteria of Behcet syndrome

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Clinical outcome measures: activity according to the current activity form Prevalence of the different organ involvement comparing western with non-western For example: percentage of patients with uveitis percentage of patients with complete blindness due to uveitis percentage of patients with diminished visus due to the uveitis comparing the prevalence between the patients in the Nederland, United States and Turkey, also comparing western (NL and US) versus non-western (Turkey)	—

Measure

Time frame

Clinical outcome measures: activity according to the current activity form Prevalence of the different organ involvement comparing western with non-western For example: percentage of patients with uveitis percentage of patients with complete blindness due to uveitis percentage of patients with diminished visus due to the uveitis comparing the prevalence between the patients in the Nederland, United States and Turkey, also comparing western (NL and US) versus non-western (Turkey)

—

Countries

Netherlands

Outcome results